| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2012 | 11th International Conference on Clean Energy (ICCE-2011) | Lee D.-J. ; Lin C.-Y.; Wu S.-Y. | International Journal of Hydrogen Energy | |||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | |||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. | Journal of the Formosan Medical Association | |||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. | Journal of the Formosan Medical Association | |||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. | Journal of the Formosan Medical Association | |||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO ; Chuang W.-L. | Journal of the Formosan Medical Association | |||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; CHUN-JEN LIU ; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. | Journal of the Formosan Medical Association | |||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; PEI-JER CHEN ; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. | Journal of the Formosan Medical Association | |||
| 2020 | 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations | Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; CHEN-HUA LIU ; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L. | Journal of the Formosan Medical Association | |||
| 2018 | 24-Hour Ambulatory Blood Pressure after Adenotonsillectomy in Childhood Sleep Apnea | Hsu W.-C.; Kang K.-T.; SHUENN-NAN CHIU ; Weng W.-C.; Lee P.-L.; Lin C.-Y. | Journal of Pediatrics | |||
| 2018 | 24-Hour Ambulatory Blood Pressure after Adenotonsillectomy in Childhood Sleep Apnea | Hsu W.-C.; Kang K.-T.; Chiu S.-N.; WEN-CHIN WENG ; Lee P.-L.; Lin C.-Y. | Journal of Pediatrics | |||
| 2018 | 24-Hour Ambulatory Blood Pressure after Adenotonsillectomy in Childhood Sleep Apnea | Hsu W.-C.; Kang K.-T.; Chiu S.-N.; Weng W.-C.; PEI-LIN LEE ; Lin C.-Y. | Journal of Pediatrics | |||
| 2015 | 3D printing bioceramic porous scaffolds with good mechanical property and cell affinity | CHIH-HAO CHANG ; Lin C.-Y.; Liu F.-H.; Chen M.H.-C.; Lin C.-P.; Ho H.-N.; Liao Y.-S. | PLoS ONE | |||
| 2015 | 3D printing bioceramic porous scaffolds with good mechanical property and cell affinity | Chang C.-H.; Lin C.-Y.; Liu F.-H.; Chen M.H.-C.; CHUN-PIN LIN ; Ho H.-N.; Liao Y.-S. | PLoS ONE | |||
| 2011 | The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1 | SZU-HUA PAN ; Chao Y.-C.; Hung P.-F.; Chen H.-Y.; Yang S.-C.; Chang Y.-L.; Wu C.-T.; Chang C.-C.; Wang W.-L.; Chan W.-K.; Wu Y.-Y.; Che T.-F.; Wang L.-K.; Lin C.-Y.; Lee Y.-C.; Kuo M.-L.; Lee C.-H.; Chen J.J.W.; Hong T.-M.; Yang P.-C. | Journal of Clinical Investigation | |||
| 2011 | The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1 | Pan S.-H.; Chao Y.-C.; Hung P.-F.; Chen H.-Y.; Yang S.-C.; Chang Y.-L.; CHEN-TU WU ; Chang C.-C.; Wang W.-L.; Chan W.-K.; Wu Y.-Y.; Che T.-F.; Wang L.-K.; Lin C.-Y.; Lee Y.-C.; Kuo M.-L.; Lee C.-H.; Chen J.J.W.; Hong T.-M.; Yang P.-C. | Journal of Clinical Investigation | |||
| 2011 | The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1 | Pan S.-H.; Chao Y.-C.; Hung P.-F.; Chen H.-Y.; Yang S.-C.; YIH-LEONG CHANG ; Wu C.-T.; Chang C.-C.; Wang W.-L.; Chan W.-K.; Wu Y.-Y.; Che T.-F.; Wang L.-K.; Lin C.-Y.; Lee Y.-C.; Kuo M.-L.; Lee C.-H.; Chen J.J.W.; Hong T.-M.; Yang P.-C. | Journal of Clinical Investigation | |||
| 2020 | Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan | Chou S.-C.; Lin C.-Y.; Yen C.-T.; Hsieh H.-N.; Huang Y.-C.; Li K.-J.; SHU-WHA LIN ; Shen M.-C. | Journal of the Formosan Medical Association | |||
| 2021 | Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan | SHENG-CHIEH CHOU ; Lin C.-Y.; Yen C.-T.; Hsieh H.-N.; Huang Y.-C.; Li K.-J.; Lin S.-W.; Shen M.-C. | Journal of the Formosan Medical Association | |||
| 2021 | Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan | Chou S.-C.; Lin C.-Y.; Yen C.-T.; Hsieh H.-N.; Huang Y.-C.; Li K.-J.; Lin S.-W.; MING-CHING SHEN | Journal of the Formosan Medical Association |
